Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis

Oncology Reports

Volumn 19, Issue 2, 2008, Pages 555-561

  Davies, Simon R ^a   Dent, Colin ^a   Watkins, Gareth ^a   King, Judy A ^b   Mokbel, Kefah ^c   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Activated leukocyte cell adhesion molecule; Breast cancer; Skeletal metastasis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ESTROGEN RECEPTOR;

ARTICLE; BONE METASTASIS; BREAST CANCER; BREAST DISEASE; CANCER CELL CULTURE; CANCER RECURRENCE; CLINICAL PRACTICE; CONTROLLED STUDY; CYTOPLASM; DEATH; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 38749140566     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.2.555     Document Type: Article

References (49)

1. American Cancer Society: Cancer Facts and Figures 2006. Atlanta, GA, 2006.
2. Fleming I, Cooper J, Henson D, Hutter R, Kennedy B, Murphy G, O'Sullivan B, Sobin L and Yarbro J: Breast. In: AJCC Cancer Staging Manual. 5th edition Lippincott-Raven, Philadelphia, pp171-178, 1997.
3. Colleoni M, O'Neill A, Goldhirsch A, Gelber RD, Bonetti M, Thürlimann B, Price KN, Castiglione-Gertsch M, Coates AS, Lindtner J, Collins J, Senn H-J, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M and Rudenstam C-M: Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol 18: 3925-3935, 2000.
4. Downey SE and Bundred NJ: Bone Metastases. In: Recent Advances in Surgery 19. 1st edition, Johnson CD (ed). Churchill Livingstone, Edinburgh, pp109-128, 1996.
5. Pourquie O, Corbel C, Le Caer J-P, Rossier J and Le Douarin N: BEN: a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc Natl Acad Sci USA 89: 5261-5265, 1992.
6. Tanaka H, Matsui T, Agata A, Tomura M, Kubota I, McFarland KC, Kohr B, Lee A, Phillips HS and Shelton DL: Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron 7: 535-545, 1991.
7. Burns F, von Kannen S, Guy L, Raper J, Kamholz J and Chang S: DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 7: 209-220, 1991.
8. Peduzzi J, Irwin M and Geisert E: Distribution and characteristics of a 90 kDa protein, KG-CAM in the rat CNS. Brain Res 640: 296-307, 1994.
9. Paschke K, Lottspeich F and Stuermer C: Neurolin, a cell surface glycoprotein on growing retinal axons in the goldfish visual systems, is re-expressed during retinal axonal regeneration. J Cell Biol 117: 863-875, 1992.
10. Degen W, van Kempen L, Gijzen E, van Groningen J, van Kooyk Y, Bloemers H and Swart GWM: MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am J Pathol 152: 805-813, 1998.
11. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang W-C, Marquardt H, Neubauer M, Pesando JM, Francke U, Haynes BF and Aruffo A: Cloning, mapping and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181: 2213-2220, 1995.
12. Bowen MA, Bajorath J, D'Egidio M, Whitney GS, Palmer D, Kobarg J, Starling GC, Siadak AW and Aruffo A: Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding. Eur J Immunol 27: 1469-1478, 1997.
13. Kurata H, Matsumoto A, Fujiwara Y, Kondo K, Itakura H, Mitchell A and Fidge N: A candidate high-density lipoprotein (HDL) receptor, HB2, with possible multiple functions shows sequence homology with adhesion molecules. J Atheroscler Thromb 4: 112-117, 1998.
14. Matsumoto A, Mitchell A, Kurata H, Pyle L, Kondo K, Itakura H and Fidge N: Cloning and characterization of HB2, a candidate high-density lipoprotein receptor. Sequence homology with members of the immunoglobulin superfamily of membrane proteins. J Biol Chem 272: 16778-16782, 1997.
15. Swart GWM: Activated leukocyte cell adhesion molecule (CD 16/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur J Cell Biol 81: 313-321 2002.
16. van Kempen LC, Nelissen JMDT, Degen WGJ, Torensma R, Weidle UH, Bloemers HPJ, Figdor CF and Swart GWM: Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276: 25783-25790, 2001.
17. van Kempen LC, Meier F, Egeblad M, Kersten-Niessen MJ, Garbe C, Weidle UH, Van Muijen GN, Herlyn M, Bloemers HP and Swart GWM: Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis. J Invest Dermatol 122: 1293-1301, 2004.
18. Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M and Rosenthal A: ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54: 34-43, 2003.
19. Weichert W, Knosel T, Bellach J, Dieal M and Kistianse G: ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 1160-1164, 2004.
20. Verma A, Shukla NK, Deo SVS, Gupta SD and Ralham R: MEMD/ALCAM: A potential marker for tumour invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 68: 463-470, 2005.
21. Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, Dowbenko D, Lasky LA and Suda T: ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 98: 2134-2142, 2001.
22. Arai F, Ohneda O, Miyamoto T, Zhang X and Suda T: Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 195: 1549-1563, 2002.
23. King JA, Al-Mehdi A-B, Ofori-Acquah SF and Stevens T: Role of ALCAM in interaction of breast cancer metastases and the endothelium of the lung. FASEB J 18: 330, 2004.
24. King JA, Ofori-Acquah SF, Stevens T, Al-Mehdi AB, Fodstad O and Jiang WG: Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6: R478-R487, 2004.
25. Jezierska A, Olszewski WP, Pietruszkiewicz J, Olszewski W, Matysiak W and Motyl T: Activated leukocyte cell adhesion molecule (ALCAM) is associated with suppression of breast cancer cells invasion. Med Sci Monit 12: BR245-BR256, 2006.
26. Jiang WG, Douglas-Jones A and Mansel RE: Level of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 69: 27-281, 2003.
27. Jiang WG, Douglas-Jones A and Mansel RE: Expression of peroxisome-proliferator activated receptor-gamma (PPARγ) and the PPARgamma co-activator, PGC-1 in human breast cancer correlates with clinical outcomes. Int J Cancer 106: 752-757, 2003.
28. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K and Mansel RE: Prognostic value of Rho GTPases and Rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 9: 6432-6440, 2003.
29. Parr C, Watkins G, Mansel RE and Jiang WG: The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 10: 202-211, 2004.
30. Al-Rawi MA, Rmali K, Watkins G, Mansel RE and Jiang WG: Aberrant expression of interleukin-7 (IL-7) and its signaling complex in human breast cancer. Eur J Cancer 40: 494-502, 2004.
31. Davies G, Cunnick GH, Mansel RE, Mason MD and Jiang WG: Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 21: 31-37, 2004.
32. Nazarenko IA, Bhatnagar SK and Hohman RJ: A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res 25: 2516-2521, 1997.
33. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE and Somlyo AP: Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 269: 652-659, 2000.
34. Cunnick GH, Jiang WG, Gomez KF and Mansel RE: Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. Biochem Biophys Res Commun 288: 1043-1046, 2001.
35. Davies G, Jiang WG and Mason MD: Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. J Urol 163: 985-992, 2000.
36. Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E and Fidler IJ: Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res 5: 25-33, 1999.
37. Burkhardt M, Mayordomo E, Winzer K-J, Fritzsche F, Gansukh T, Pahl S, Weichert W, Denkert C, Guski H, Dietel M and Kristiansen G: Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59: 403-409, 2006.
38. + human bone marrow cells. Blood 89: 2706-2716, 1997.
39. Stephan J-P, Bald L, Roberts PE, Lee J, Gu Q and Mather JP: Distribution and function of the adhesion molecule BEN during rat development. Dev Biol 212: 264-277, 1999.
40. Corbel C, Bluestein HG, Pourquie O, Vaigot P and Le Douarin NM: An antigen expressed by avian neuronal cells is also expressed by activated T lymphocytes. Cell Immunol 141: 99-110, 1992.
41. Corbel C, Pourquie O, Cormier F, Vaigot P and Le Douarin NM: BEN/SC1/ DM-GRASP, a homophilic adhesion molecule, is required for in vitro myeloid colony formation by avian hemopoietic progenitors. Proc Natl Acad Sci USA 93: 2844-2849, 1996.
42. Ellis I, Pinder S, Lee A and Elston C: Tumours of the Breast. In: Diagnostic Histopathology of Tumours. 2nd edition, Fletcher C (ed). Churchill Livingstone, New York, pp865-930, 2000.
43. Galea MH, Blamey RW, Elston CE and Ellis IO: The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22: 207-219, 1992.
44. Miller W, Ellis I, Sainsbury J and Dixon J: ABC of breast diseases. Prognostic factors. Br J Med 309: 1573-1576, 1994.
45. Moll R, Mitze M, Frixen UH and Birchmeier W: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143: 1731-1742, 1993.
46. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H and Gown AM: E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 115: 534-542, 2001.
47. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA and Zhang PJ: Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115: 85-98, 2001.
48. Jiang WG: E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 83: 437-446, 1996.
49. Tomita K, van Bokhoven A, Jansen CFJ, Bussemakers MJG and Schalken JA: Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by a-catenin. Biochem Biophys Res Commun 267: 870-874, 2000.